Physician profile
Lekshmi Seemanthini
NPI 1326229352
$3,142.57
in general payments reported to CMS, 2019-2025
22 companies · $627 in 2025
The $627 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $54.07 · 2021: $277 · 2022: $710 · 2023: $589 · 2024: $578 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,727 · Education: $66.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,727.32 |
| Education | $66.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,239.91 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $262.60 | 2021-2024 | |
| Pfizer INC. | $259.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.97 | 2020-2025 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $152.63 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $149.55 | 2021-2023 | Verquvo |
| Inari Medical, INC. | $123.18 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $122.87 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $104.75 | 2022-2024 | Repatha |
| Abbott Laboratories | $103.83 | 2019-2023 | Cardiomems |
| Actelion Pharmaceuticals US, INC. | $103.82 | 2023 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $69.21 | 2021-2024 | |
| Medtronic, INC. | $32.84 | 2021-2022 | |
| Boston Scientific Corporation | $30.58 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $29.83 | 2024 | Arcalyst |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.95 | 2021-2022 | |
| Cvrx, INC. | $27.56 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $20.56 | 2019 | |
| G Medical Diagnostic Services, INC. | $19.62 | 2019 | |
| Medtronic Vascular, INC. | $15.89 | 2020 | |
| Angiodynamics, INC. | $15.12 | 2023 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $13.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lekshmi Seemanthini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.